Question 1

What specific symptoms of allergic rhinitis might montelukast help with?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) clinical trial (NCT00092885). Contact the study team or your healthcare provider for specific answers.

Question 2

How does montelukast compare to my current allergy treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) clinical trial (NCT00092885). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) clinical trial (NCT00092885). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my asthma be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) clinical trial (NCT00092885). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience any adverse effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) clinical trial (NCT00092885). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) clinical trial (NCT00092885). Contact the study team or your healthcare provider for specific answers.

What this study is about